Immuron Limited announced the appointment of Paul Brennan as an independent Non-Executive Director of the Company with effect from 16 March 2022. Mr. Brennan was Chief Executive Officer (CEO) of PolyNovo Limited for 7 years from 2015 to 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.086 AUD | +1.18% |
|
-2.27% | +11.69% |
Jul. 03 | Immuron Files for Mixed-Shelf Offering; Plans to Raise $2M Through At-The-Market Equity Sale | MT |
Jul. 02 | Immuron Requests Meeting With FDA for Potential Colon Infection Therapy | MT |
1st Jan change | Capi. | |
---|---|---|
+11.69% | 13.32M | |
+6.96% | 101B | |
+8.29% | 42.63B | |
-11.09% | 33.5B | |
+82.32% | 29.77B | |
-11.82% | 16.14B | |
+1.39% | 14.31B | |
-12.13% | 11.55B | |
+176.65% | 10.53B | |
+6.74% | 9.2B |
- Stock Market
- Equities
- IMC Stock
- News Immuron Limited
- Immuron Limited Announces Appointment of Paul Brennan as Non-Executive Director